A NEW POSSIBILITY FOR BODY CONTROL ?

Scientists are excitedly investigating retatrutide, a novel drug created by Eli Lilly, as a significant breakthrough in body management. Different than many earlier approaches, retatrutide is a double -action receptor targeting both GLP-1 and GIP, hormones that impact hunger and blood glucose ba